Editorial
Published in:
Transfuze Hematol. dnes,30, 2024, No. 1, p. 3.
Category:
Editorial
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2024 Issue 1
- Neutralizing Antibodies Against Emicizumab – Detailed Analysis Based on a Case Study
- Position of aPCC in the Treatment of Hemophilia A Complicated by the Development of Inhibitors
- Sport and Physical Activity Benefit Hemophiliacs
- What FVIII Levels Are Ideal for Preventing Bleeding in Hemophilia A?
- Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures
Most read in this issue
- Therapy targeting CD19 antigen in diffuse large B-cell lymphoma
- Descriptive epidemiology of selected haemato-oncological diseases in the Czech Republic
- Primary multifocal extramedullary multiple myeloma with a rare cytogentic abnormality
- Artificial intelligence in bone marrow cytomorphology: Morphogo and Scopio